Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-06

Clinical Trial Update: The Efficacy of Dietary Flaxseed for the Reduction of Blood Pressure in Newly Diagnosed Hypertensive Individuals [Phase 2, Phase 3]

View source ↗

Summary

Trial update on dietary flaxseed for reducing blood pressure in newly diagnosed hypertension; study terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Boniface Hospital | Conditions: Hypertension | Phase 2, Phase 3 | Status: TERMINATED